Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap14.84B
Enterprise Value14.06B
P/E Ratio26.78
PEG Ratio2.87
Price/Sales Ratio10.26
Price/Book Ratio3.92
Enterprise/Revenue9.58
Enterprise/EBITDA21.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.38
Operating Margin0.4
AD

Management Effectiveness

Return On Assets0.13
Return On Equity0.15

Income Statement

Revenue1.06B
Revenue/Share2.14
Gross Profit1.01B
EBITDA489.25M
Net Income380.94M
Diluted EPS0.73

Balance Sheet

Total Cash1.33B
Total Cash/Share2.55
Total Debt12.15M
Total Debt/Equity0
Current Ratio12.11
Book Value Per Share5.76

Price History

52-Week Change-32.27
52-Week High33.85
52-Week Low18.48
Moving Average 50 Days20.4
Moving Average 200 Days23.6

Statistics

Average Volume10.37M
Shares Outstanding523.58M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield1.14
Payout Ratio0.12
Last Split Factor9:5
Last Split DateMay 08, 2019
AD